Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Trevena Has Been Granted U.S. Patent 11,912,713 Titled "7-membered Aza-Heterocyclic Containing Delta-Opioid Receptor Modulating Compounds, Methods Of Using And Making (For Treating Pain, Migraines, Depression, Parkinsons Disease, And Other Disorders)

Author: Benzinga Newsdesk | February 27, 2024 01:33pm

https://ppubs.uspto.gov/pubwebapp/external.html?q=(11912713).pn

Posted In: TRVN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist